Following a 26 May pitch contest at Barcelona Science Park, five start-ups were selected to receive a total of €50 000 in funding each in the EIT Health Spain Headstart 2017 competition.When the Headstart 2017 call closed, EIT Health Spain had received a total of 46 proposals, and these were winnowed down to 10 finalists, who participated in the pitch. The five winners chosen after making their pitchers are:
Avizorex Pharma: A phase I/II proof-of-concept clinical study double-blind, placebo-controlled study assessing the safaty and efficacy of AVX-012 ophthalmic solution in subjetcs with mild to moderate dry eye syndrome.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.